Myosin inhibitors may be effective in HFpEF

Myosin inhibitors may be effective in HFpEF

0 Comments

medicine Friday, October 25, 2024 Boston – Myosin inhibitors such as mavacamten, approved for the treatment of hypertrophic obstructive cardiomyopathy, may also be effective in heart failure with preserved ejection fraction (HFpEF). This is suggested

How RAS inhibitors affect the aggressiveness of prostate cancer

How RAS inhibitors affect the aggressiveness of prostate cancer

0 Comments

Leipzig – The prostate cancers of patients treated with renin-angiotensin system (RAS) inhibitors are less aggressive than tumors that are RAS inhibitor-naive. This is suggested by new data presented by Nastasiia Artamonova, Medical University of